AI-Powered News Analysis•Compare coverage across the political spectrum
GoodPointsNews
Admin
Back to Dashboard
Roche's obesity drug boosts blood sugar control, drives 15.5% weight loss in mid-stage trial - Reuters

Roche's obesity drug boosts blood sugar control, drives 15.5% weight loss in mid-stage trial - Reuters

Roche's obesity drug boosts blood sugar control, drives 15.5% weight loss in mid-stage trial Reuters

September 22, 2026 at 11:25 AM Original source
1 agencies covered this story

Coverage by Political Leaning

See how different sides of the spectrum reported this story

Left
0 articles
No coverage
Lean Left
0 articles
No coverage
Center
1 articles
Lean Right
0 articles
No coverage
Right
0 articles
No coverage

Key People

No people linked to this story

Locations

Switzerland United States

Tags

blood sugar blood sugar control drug trial obesity pharmaceuticals roche weight loss

All Coverage

Roche's obesity drug boosts blood sugar control, drives 15.5% weight loss in mid-stage trial - Reuters
Reutersvia rss

<a href="https://news.google.com/rss/articles/CBMi5gFBVV95cUxNeUx3UTJqdzlXSGRtb2xZSzBseG9NaVJtdmk4ZnRhai1oNmxUYWpTeUpwUU1TYm1keGVhZ2RrNENvX0ZmV0U2UVY5cHRObGRVd2NWOXlIZ2EyWWxKZkV1Nkc5cDNWRXh1UzVBR0J3Ymdzeml1U0I3bC1kWHlpWjBXVXl2cmRzZEV2TjFBSTlkb0Y1QkEwcWtyblduajRJV0RORGpqVG9iWmI1NjZRUmtkSGZvNjZ1T3gtYThqTVV3V2toOGx4VUUtU0dZUzN5eDNaS1JJSWR5R3VIWFhhcTZXRlJ3VkFaZw?oc=5" target="_blank">Roche's obesity drug boosts blood sugar control, drives 15.5% weight loss in mid-stage trial</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

100%

Similar Stories

Related coverage based on topic and tags

Viking Therapeutics' obesity drug shows durable weight-loss benefit, shares surge - Reuters

Viking Therapeutics' obesity drug shows durable weight-loss benefit, shares surge Reuters

September 22, 2026 at 08:10 PM

Novo CEO says pills could capture 50% of weight-loss market by 2030 - Reuters

Novo CEO says pills could capture 50% of weight-loss market by 2030 Reuters

September 22, 2026 at 03:16 PM

Merck's drug for diabetes-related eye disease meets trial goal - Reuters

Merck's drug for diabetes-related eye disease meets trial goal Reuters

September 24, 2026 at 02:52 PM

Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs - reuters.com

Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs reuters.com

September 21, 2026 at 05:02 AM

US FDA approves AbbVie's drug for Parkinson's disease - reuters.com

US FDA approves AbbVie's drug for Parkinson's disease reuters.com

September 25, 2026 at 10:57 PM

Novo Nordisk open to direct New York listing, CEO Doustdar tells FT - Reuters

Novo Nordisk open to direct New York listing, CEO Doustdar tells FT Reuters

September 23, 2026 at 04:13 AM